GB0011071D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0011071D0
GB0011071D0 GBGB0011071.8A GB0011071A GB0011071D0 GB 0011071 D0 GB0011071 D0 GB 0011071D0 GB 0011071 A GB0011071 A GB 0011071A GB 0011071 D0 GB0011071 D0 GB 0011071D0
Authority
GB
United Kingdom
Prior art keywords
sub
organic compounds
formula
compounds
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0011071.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0011071.8A priority Critical patent/GB0011071D0/en
Publication of GB0011071D0 publication Critical patent/GB0011071D0/en
Priority to PCT/EP2001/005162 priority patent/WO2001085718A1/en
Priority to JP2001582319A priority patent/JP2003532724A/ja
Priority to AU73998/01A priority patent/AU7399801A/en
Priority to CA002405968A priority patent/CA2405968A1/en
Priority to DE60139770T priority patent/DE60139770D1/de
Priority to EP01940412A priority patent/EP1282617B1/en
Priority to PT01940412T priority patent/PT1282617E/pt
Priority to AT01940412T priority patent/ATE441642T1/de
Priority to ES01940412T priority patent/ES2330305T3/es
Priority to US10/333,388 priority patent/US7019004B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GBGB0011071.8A 2000-05-08 2000-05-08 Organic compounds Ceased GB0011071D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0011071.8A GB0011071D0 (en) 2000-05-08 2000-05-08 Organic compounds
US10/333,388 US7019004B2 (en) 2000-05-08 2001-05-07 Hydantoin derivatives with affinity for somatostatin receptors
CA002405968A CA2405968A1 (en) 2000-05-08 2001-05-07 Hydantoin derivatives with affinity for somatostatin receptors
JP2001582319A JP2003532724A (ja) 2000-05-08 2001-05-07 ソマトスタチン誘導体に親和性を有する、ヒダントイン誘導体
AU73998/01A AU7399801A (en) 2000-05-08 2001-05-07 Hydantoin derivatives with affinity for somatostatin receptors
PCT/EP2001/005162 WO2001085718A1 (en) 2000-05-08 2001-05-07 Hydantoin derivatives with affinity for somatostatin receptors
DE60139770T DE60139770D1 (de) 2000-05-08 2001-05-07 Hydantoin derivate mit affinität für somatostatin rezeptoren
EP01940412A EP1282617B1 (en) 2000-05-08 2001-05-07 Hydantoin derivatives with affinity for somatostatin receptors
PT01940412T PT1282617E (pt) 2000-05-08 2001-05-07 Derivados de hidantoína com afinidade para os receptores da somatostatina
AT01940412T ATE441642T1 (de) 2000-05-08 2001-05-07 Hydantoin derivate mit affinität für somatostatin rezeptoren
ES01940412T ES2330305T3 (es) 2000-05-08 2001-05-07 Derivados de hidantoina con afinidad por los receptores de la somatostatina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0011071.8A GB0011071D0 (en) 2000-05-08 2000-05-08 Organic compounds

Publications (1)

Publication Number Publication Date
GB0011071D0 true GB0011071D0 (en) 2000-06-28

Family

ID=9891182

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0011071.8A Ceased GB0011071D0 (en) 2000-05-08 2000-05-08 Organic compounds

Country Status (11)

Country Link
US (1) US7019004B2 (https=)
EP (1) EP1282617B1 (https=)
JP (1) JP2003532724A (https=)
AT (1) ATE441642T1 (https=)
AU (1) AU7399801A (https=)
CA (1) CA2405968A1 (https=)
DE (1) DE60139770D1 (https=)
ES (1) ES2330305T3 (https=)
GB (1) GB0011071D0 (https=)
PT (1) PT1282617E (https=)
WO (1) WO2001085718A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
AU2002363655A1 (en) * 2001-11-14 2003-05-26 Novartis Ag Non-peptide somatostatin receptor ligands
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
SI2384753T1 (sl) 2003-08-29 2016-06-30 The Brigham And Women's Hospital, Inc. Hidantoinski derivati kot inhibitorji celične nekroze
CA2772760A1 (en) 2008-12-23 2010-07-01 President And Fellows Of Harvard College Small molecule inhibitors of necroptosis
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
EP3229807A4 (en) 2014-12-11 2018-10-17 President and Fellows of Harvard College Inhibitors of cellular necrosis and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859190A (en) * 1997-02-04 1999-01-12 Trega Biosciences, Inc. Combinatorial libraries of hydantoin and thiohydantoin derivatives, methods of making the libraries and compounds therein
FR2796945B1 (fr) * 1999-07-30 2002-06-28 Sod Conseils Rech Applic Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
AU2002363655A1 (en) * 2001-11-14 2003-05-26 Novartis Ag Non-peptide somatostatin receptor ligands
US7189856B2 (en) * 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands

Also Published As

Publication number Publication date
AU7399801A (en) 2001-11-20
WO2001085718A1 (en) 2001-11-15
PT1282617E (pt) 2009-12-09
US20040110779A1 (en) 2004-06-10
EP1282617A1 (en) 2003-02-12
DE60139770D1 (de) 2009-10-15
EP1282617B1 (en) 2009-09-02
JP2003532724A (ja) 2003-11-05
CA2405968A1 (en) 2001-11-15
ES2330305T3 (es) 2009-12-09
ATE441642T1 (de) 2009-09-15
US7019004B2 (en) 2006-03-28

Similar Documents

Publication Publication Date Title
MY129613A (en) Cannabinoid receptor binding compounds
GB0128996D0 (en) Organic compounds
ATE270817T1 (de) Fungizide
WO2003016282A3 (en) Substituted 1h-dihydropyrazoles, their preparation and use
IL157773A0 (en) 2-amino-propanol derivatives
SE0004245D0 (sv) Novel compounds and their use
GB9929552D0 (en) Compounds
GB0114185D0 (en) Compounds
MY133969A (en) Indoloquinazolinones
GB0011071D0 (en) Organic compounds
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
CA2356985A1 (en) 5ht1 antagonists for antidepressant therapy
BG105847A (en) Calcilytic compounds
DK1204659T3 (da) Serotonerge benzofuraner
EP1189909A4 (en) NOVEL ALUMINOSILOXANE COMPOUNDS, AND PROCESS FOR THEIR PREPARATION
DE60001366D1 (de) Orale zusammensetzung enthaltend perlit
WO2003042234A3 (en) Non-peptide somatostatin receptor ligands
WO2004024681A3 (fr) NOUVEAUX COMPOSES COMPRENANT UN GROUPEMENT THIOCARBONYLSULFANYLE UTILES POUR LA SYNTHESE DE COMPOSES α-PERFLUOROALKYLAMINES PAR VOIE RADICALAIRE
ID27440A (id) Proses untuk menyiapkan penengah-penengah
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
ZA983231B (en) Substituted benzyloxyimino compounds.
IL159493A0 (en) Pharmaceutical formulation containing an ltb4 antagonist
GB0322750D0 (en) Organic compounds
PL365687A1 (en) Novel trioxepan compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)